Clatterbridge Cancer Centre is upgrading its treatment verification system for ocular proton therapy to improve patient positioning and treatment accuracy.
Tender closed on 7 Aug 2026. Awaiting award.
No single supplier dominates the field.
In healthcare medical, The Clatterbridge Cancer Centre NHS Foundation Trust has awarded 3 contracts to 2 suppliers.
Across healthcare medical, the most active winners are URTICA SP Z O O, SALUS INTERNATIONAL SP Z O O, URTICA SP Z OO — the field to beat, or your route in as a partner.
Clatterbridge Cancer Centre NHS Foundation Trust seeks a comprehensive radiopharmaceuticals service provider for cancer diagnostics and therapy, including cyclotron-based radiopharmacy and multiple radiopharmaceutical production capabilities.
Procurement for supply and administration services of CAR-T cell therapies Yescarta and Tecartus for cancer treatment.
NHS England is procuring Breyanzi CAR-T cell therapy products for direct supply to the National Health Service.
Clatterbridge Cancer Centre seeks a Building Management System provider to integrate facility controls and monitoring across its Aintree location.
Develop medical countermeasures for CBRN threats with up to £4 million funding over 30 months, from prototype through Phase 2a clinical studies.
A three-year funded fellowship helping healthcare professionals with PhDs return to clinical research after extended career breaks.
UKHSA is seeking suppliers for Diphtheria Antitoxin through a market engagement exercise for 2026 delivery.
Procurement of a slit-lamp simulator system with all components and software for ophthalmology training and education.
